Keeping a close watch for QPP developments

Jan 03, 2021 Re-posted from the January 2021 issue of Vascular Specialist

By Beth Bales

The Quality and Performance Measures Committee (QPMC) is tasked with monitoring and creating national performance measures that are relevant to vascular surgeons.

Ever since the Quality Performance Program (QPP) was implemented in 2016, a major focus of the QPMC has been advocating for vascular surgeons on QPP requirements, educating the SVS membership about QPP and working to create mechanisms for vascular surgeons to be successful in it—all physicians who bill Medicare are required to participate adequately in QPP or face a financial penalty.

With Karen Woo, MD, as chair, in 2021 the QPMC will continue to monitor for QPP developments that may affect vascular surgeons and address them to the extent possible. As of the final rule for 2021, the Centers for Medicare and Medicaid Services (CMS) plans to implement in 2022 the Merit-Based Incentive Payment System (MIPS) Value Programs (MVPs). That will see the QPMC make a major push to create a vascular surgery MVP proposal for CMS to consider, Woo explains.

The committee accomplished significant work on this proposal in 2020, with the development of performance measures and data analysis to support their validity. This work will continue in 2021 with a focus on publishing a white paper on the topic of patient-reported outcomes relevant to vascular surgeons, on which CMS has placed great emphasis. “The QPMC has always and will continue to work tirelessly to optimize performance measures for vascular surgeons and the delivery of care to our vascular patients,” says Woo.

Tags
Vascular Specialist

Related Articles

Why donate to the SVS PAC?

A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.

Progress made during year like no other

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.

New SVS vice president, revised bylaws set to be unveiled at June 16 Annual Business Meeting

Members, be sure to register for the June 16 Virtual Annual Business Meeting, the first of two business meetings for 2021. Registration is required to assure A quorum. Register at vascular.org/ABM1Register. The second meeting will be held Saturday, Aug. 21, during the Vascular Annual Meeting (VAM). The Wednesday, June 16, meeting will be from 6 to 7 p.m. Central Daylight Time. Members will hear reports from President Ronald L. Dalman, MD, Secretary Amy Reed, MD, and Treasurer Keith Calligaro, MD. Nominating Committee Chair R. Clement Darling III, MD, will present his report, announce the results of the election for SVS vice president and on bylaws revisions, and introduce the 2021–22 Officers.